title: Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy.
abstract: This review addresses different aerosol therapies used to treat the underlying cause and symptoms of cystic fibrosis (CF) during the past two decades. A summary of the current methods of aerosol delivery and suggestions that may improve the efficacy of the current treatments are provided.
authors.affiliation: Division of Drug Delivery and Disposition, School of Pharmacy, Beard Hall, CB #7360 University of North Carolina, Chapel Hill, NC 27599, USA. lgarciac@email.unc.edu
authors.forename: Lucila
authors.initials: L
authors.lastname: Garcia-Contreras
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Hickey
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000628:therapy*; D004355:Drug Stability; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage; D006801:Humans; D009330:Nebulizers and Vaporizers; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry*
chemical_list: D000336:Aerosols; D004364:Pharmaceutical Preparations